Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
hepatic insufficiency
,
type 2 diabetes mellitus
,
prediabetic state
,
insulin resistance
,
glucose intolerance
,
fibromyalgia
,
healthy volunteers/patients
,
pain
,
diabetic neuropathies
,
diabetes mellitus
,
peripheral nervous system diseases
,
sleep initiation and maintenance disorders
,
cardiovascular diseases
,
neoplasms
,
postpartum depression
,
myofascial pain syndromes
,
menopause
,
major depressive disorder
,
depressive disorder
,
depression
,
hot flashes
,
dysthymic disorder
,
anxiety disorders
,
pharmacokinetics
,
anhedonia
,
generalized anxiety disorder
,
breast neoplasms
,
opioid-related disorders
,
vascular depression
,
social phobia
,
neuroticism
,
medically unexplained symptoms
,
bipolar disorder
,
cancer pain
,
vomiting
,
nausea
,
adjustment disorders
Glycididazole
carcinoma
,
esophageal neoplasms
,
squamous cell carcinoma
Taxane
pancreatic neoplasms
,
small cell lung carcinoma
,
small cell carcinoma
,
urethral neoplasms
,
pharmacokinetics
,
non-hodgkin lymphoma
,
lymphoma
,
hodgkin disease
,
follicular lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
neoplasms
,
castration-resistant prostatic neoplasms
,
head and neck neoplasms
,
melanoma
,
hepatocellular carcinoma
,
squamous cell neoplasms
,
renal cell carcinoma
,
urologic neoplasms
,
colorectal neoplasms
,
sarcoma
,
liver neoplasms
,
transitional cell carcinoma
,
invasive hydatidiform mole
,
disease
,
male breast neoplasms
,
cholangiocarcinoma
,
gallbladder neoplasms
,
hereditary breast and ovarian cancer syndrome
,
thymoma
,
mouth neoplasms
,
oropharyngeal neoplasms
,
neoplasms by histologic type
,
neoplasms by site
,
glandular and epithelial neoplasms
,
hypopharyngeal neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
hypoxia
,
vomiting
,
nausea
,
endometrioid carcinoma
,
nasopharyngeal carcinoma
,
laryngeal neoplasms
,
pancreatic ductal carcinoma
,
biliary tract neoplasms
,
adenosquamous carcinoma
,
anus neoplasms
,
non-small-cell lung carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
ovarian neoplasms
,
lung neoplasms
,
carcinoma
,
endometrial neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
prostatic neoplasms
,
neoplasm metastasis
,
fallopian tube neoplasms
,
uterine cervical neoplasms
,
squamous cell carcinoma
,
ovarian epithelial carcinoma
,
esophageal squamous cell carcinoma
,
recurrence
,
urinary bladder neoplasms
,
peritoneal neoplasms
,
nasopharyngeal neoplasms
,
hepatitis b
,
whooping cough
,
herpes zoster
,
mumps
,
tetanus
,
diphtheria
,
measles
,
haemophilus infections
,
chickenpox
,
poliomyelitis
,
rubella
,
squamous cell carcinoma of head and neck
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use